Phase I trial of 1α-hydroxyvitamin D2 in patients with hormone refractory prostate cancer
暂无分享，去创建一个
R. Mazess | G. Wilding | R. Bruskewitz | H. Bailey | Abhik Bhattacharya | R. Arzoomanian | D. Alberti | Glenn Liu | G. Ripple | M. Staab | K. Oettel | R. Marnocha | C. Bishop | D. Horvath